Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. Post author:Sam Post published:December 18, 2017 Post category:BioPharma The FDA broke new ground today with a first-of-its-kind therapy for eye disease. Source: BioSpace You Might Also Like This is What Amazon Can Do to Start Selling Drugs Faster November 21, 2017 BioSpace Partners With To Offer Cost Savings To Members July 11, 2017 ImmunoCellular Therapeutics To Report Fourth Quarter And Full Year 2016 Financial Results On March 9, 2017 March 6, 2017
ImmunoCellular Therapeutics To Report Fourth Quarter And Full Year 2016 Financial Results On March 9, 2017 March 6, 2017
